STACI JOHNSON: Open Payments
NPI 1538325907 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 33 payments from 10 companies in 2025. Trend: 2023 $189 · 2024 $1,042 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $437 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Novo Nordisk Inc | 3 | $56 |
| PFIZER INC. | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Radius Health, Inc. | 1 | $29 |
| ViiV Healthcare Company | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, AIRSUPRA, CAPLYTA, Wegovy, NURTEC ODT, XIFAXAN, PONVORY.
Industry payments across AK — which companies pay providers there.
